【clutch now working no hesi】Imagine Owning ImmunoPrecise Antibodies (CVE:IPA) And Wondering If The 44% Share Price Slide Is Justified
While not a mind-blowing move,clutch now working no hesi it is good to see that the
ImmunoPrecise Antibodies Ltd.
(
CVE:IPA
) share price has gained 19% in the last three months. But that doesn't help the fact that the three year return is less impressive. In fact, the share price is down 44% in the last three years, falling well short of the market return.
See our latest analysis for ImmunoPrecise Antibodies
ImmunoPrecise Antibodies isn't currently profitable, so most analysts would look to revenue growth to get an idea of how fast the underlying business is growing. When a company doesn't make profits, we'd generally expect to see good revenue growth. That's because fast revenue growth can be easily extrapolated to forecast profits, often of considerable size.
In the last three years, ImmunoPrecise Antibodies saw its revenue grow by 56% per year, compound. That's well above most other pre-profit companies. While its revenue increased, the share price dropped at a rate of 17% per year. That seems like an unlucky result for holders. It seems likely that actual growth fell short of shareholders' expectations. Still, with high hopes now tempered, now might prove to be an opportunity to buy.
The company's revenue and earnings (over time) are depicted in the image below (click to see the exact numbers).
TSXV:IPA Income Statement, January 1st 2020
We consider it positive that insiders have made significant purchases in the last year. Even so, future earnings will be far more important to whether current shareholders make money. Before buying or selling a stock, we always recommend a close examination of
historic growth trends, available here.
.
A Different Perspective
ImmunoPrecise Antibodies shareholders are down 17% for the year, but the broader market is up 18%. Of course the long term matters more than the short term, and even great stocks will sometimes have a poor year. Shareholders have lost 17% per year over the last three years, so the share price drop has become steeper, over the last year; a potential symptom of as yet unsolved challenges. We would be wary of buying into a company with unsolved problems, although some investors will buy into struggling stocks if they believe the price is sufficiently attractive. Investors who like to make money usually check up on insider purchases, such as the price paid, and total amount bought.
You can find out about the insider purchases of ImmunoPrecise Antibodies by clicking this link.
ImmunoPrecise Antibodies is not the only stock insiders are buying. So take a peek at this
free
list of growing companies with insider buying.
Story continues
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on CA exchanges.
If you spot an error that warrants correction, please contact the editor at
. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.
We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.
View comments
(责任编辑:Comprehensive)
- ·From wagyu beef to melons, Japan's $2.2 trillion virus rescue piques struggling firms
- ·Why Semtech (SMTC) Stock Might be a Great Pick
- ·Ingredion Incorporated Reports Third Quarter 2020 Results
- ·Pacific Empire Announces Engagement of OreQuest Consultants as Technical Advisors and the Sale of Shares of Nova Royalty Corp. for Proceeds of Approximately C$644,795
- ·'Unsustainable': Mexico's Pemex buckling under crushing pension debt
- ·Are Options Traders Betting on a Big Move in Penn National (PENN) Stock?
- ·Guggenheim Energy & Income Fund Announces Tender Offer
- ·Song of Red Star Youth Music Project Show the Confidence of Chinese Young Generation
- ·Media Stock Earnings Roster This Week: DISCA, FOXA & More
- ·Westland Insurance Acquires Diamond Insurance Agencies in Alberta
- ·Dow Inc. (DOW) Gains But Lags Market: What You Should Know
- ·AUD/USD Weekly Price Forecast – Australian Dollar Rallies Significantly For The Week
- ·Video Meetings Can Be Superior Meetings
- ·Global core material market size to record unprecedented growth through 2025
- ·Business owners contend with threat, reality of coronavirus
- ·Companies slammed by coronavirus look to cut contributions to their employees' 401(k)s
- ·Pompeo says U.S. considering welcoming Hong Kong people, entrepreneurs
- ·HSBC adds former co-CEO of world's biggest hedge fund Bridgewater Associates to board
- ·Is the Options Market Predicting a Spike in Seagate (STX) Stock?
- ·A2Z Technologies Lists on Frankfurt Stock Exchange